243 related articles for article (PubMed ID: 24262917)
1. Autologous haematopoietic stem cell transplantation: a viable treatment option for CIDP.
Press R; Askmark H; Svenningsson A; Andersen O; Axelson HW; Strömberg U; Wahlin A; Isaksson C; Johansson JE; Hägglund H
J Neurol Neurosurg Psychiatry; 2014 Jun; 85(6):618-24. PubMed ID: 24262917
[TBL] [Abstract][Full Text] [Related]
2. Autologous Hematopoietic Stem Cell Transplantation for Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
Masson-Roy J; Breiner A; Warman-Chardon J; Pringle CE; Allan D; Bredeson C; Huebsch L; Kekre N; Kennah ML; Martin L; McDiarmid S; Altouri S; Atkins H; Bourque PR
Can J Neurol Sci; 2021 Nov; 48(6):760-766. PubMed ID: 33631093
[TBL] [Abstract][Full Text] [Related]
3. Chronic inflammatory demyelinating polyradiculoneuropathy: a role for haematopoietic stem cell transplantation?
Kazmi MA; Mahdi-Rogers M; Sanvito L
Autoimmunity; 2008 Dec; 41(8):611-5. PubMed ID: 18958756
[TBL] [Abstract][Full Text] [Related]
4. Are the treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) effective and safe? - A Cochrane Overview summary with commentary.
Oaklander AL; Gimigliano F
NeuroRehabilitation; 2019; 44(4):609-612. PubMed ID: 31256085
[TBL] [Abstract][Full Text] [Related]
5. Different electrophysiological profiles and treatment response in 'typical' and 'atypical' chronic inflammatory demyelinating polyneuropathy.
Kuwabara S; Isose S; Mori M; Mitsuma S; Sawai S; Beppu M; Sekiguchi Y; Misawa S
J Neurol Neurosurg Psychiatry; 2015 Oct; 86(10):1054-9. PubMed ID: 25424435
[TBL] [Abstract][Full Text] [Related]
6. Office immunotherapy in chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy.
Dyck PJ; Taylor BV; Davies JL; Mauermann ML; Litchy WJ; Klein CJ; Dyck PJ
Muscle Nerve; 2015 Oct; 52(4):488-97. PubMed ID: 25976871
[TBL] [Abstract][Full Text] [Related]
7. [Autologous hematopoietic stem cell transplantation for chronic inflammatory demyelinating polyneuropathy].
Urbain F; Labeyrie C; Castilla-Llorente C; Cintas P; Puma A; Maubeuge N; Puyade M; Farge D
Rev Med Interne; 2021 Sep; 42(9):639-649. PubMed ID: 33773849
[TBL] [Abstract][Full Text] [Related]
8. Progress in Hematopoietic Stem Cell Transplantation for CIDP.
Qin Z; Huang Q; Zou J; Tang L; Hu Z; Tang X
Int J Med Sci; 2020; 17(2):234-241. PubMed ID: 32038107
[TBL] [Abstract][Full Text] [Related]
9. [Preliminary assessment of immune reconstitution after autologous peripheral hematopoietic stem cell transplantation (AHSCT)].
Huang HQ; Cai QC; Shi YX; Lin XB; Wei J; Guo Y; Pan ZH
Ai Zheng; 2006 Aug; 25(8):1023-8. PubMed ID: 16965687
[TBL] [Abstract][Full Text] [Related]
10. Chronic inflammatory demyelinating polyneuropathy and pregnancy: systematic review.
Kohle F; Kuwabara S; Lehmann HC
J Neurol Neurosurg Psychiatry; 2021 May; 92(5):473-478. PubMed ID: 33563801
[TBL] [Abstract][Full Text] [Related]
11. In persons with CIDP, auto-HSCT can be conducted fully on an outpatient basis and induces significant clinical responses: A prospective study in a single center.
Montes-Robles MA; Gallardo-Pérez MM; Hernández-Flores EJ; Pastelín-Martínez ML; Sánchez-Bonilla D; Robles-Nasta M; Ocaña-Ramm G; Olivares-Gazca JC; Ruiz-Delgado GJ; Ruiz-Argüelles GJ
Transpl Immunol; 2023 Dec; 81():101944. PubMed ID: 37866669
[TBL] [Abstract][Full Text] [Related]
12. Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial.
Hughes RA; Donofrio P; Bril V; Dalakas MC; Deng C; Hanna K; Hartung HP; Latov N; Merkies IS; van Doorn PA;
Lancet Neurol; 2008 Feb; 7(2):136-44. PubMed ID: 18178525
[TBL] [Abstract][Full Text] [Related]
13. Conventional and unconventional therapies in typical and atypical chronic inflammatory demyelinating polyneuropathy with different clinical course of progression.
Hung SKY; Hiew FL; Viswanathan S; Puvanarajah S
J Peripher Nerv Syst; 2018 Sep; 23(3):183-189. PubMed ID: 30027593
[TBL] [Abstract][Full Text] [Related]
14. Successful autologous hematopoietic stem cell transplantation in a refractory anti-Caspr1 antibody nodopathy.
Afanasiev V; Tsouni P; Kuntzer T; Cairoli A; Delmont E; Vallat JM; Devaux J; Théaudin M
J Peripher Nerv Syst; 2024 Mar; 29(1):116-119. PubMed ID: 38123899
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up after autologous hematopoietic stem cell transplantation for low-grade non-Hodgkin lymphoma.
Laudi N; Arora M; Burns LJ; Miller JS; McGlave PB; Barker JN; Ramsay NK; Orchard PJ; Macmillan ML; Weisdorf DJ
Biol Blood Marrow Transplant; 2005 Feb; 11(2):129-35. PubMed ID: 15682074
[TBL] [Abstract][Full Text] [Related]
16. Refractory CIDP successfully treated with autologous haematopoietic stem cell transplantation in a patient with monoclonal gammopathy of undetermined significance (MGUS) and rheumatoid arthritis.
Lopes C; Costa A; Bergantim R; Silveira F; Nadais G
Neuromuscul Disord; 2022 Jan; 32(1):71-74. PubMed ID: 34920930
[TBL] [Abstract][Full Text] [Related]
17. Intravenous immunoglobulin response in treatment-naïve chronic inflammatory demyelinating polyradiculoneuropathy.
Kuitwaard K; Hahn AF; Vermeulen M; Venance SL; van Doorn PA
J Neurol Neurosurg Psychiatry; 2015 Dec; 86(12):1331-6. PubMed ID: 25515502
[TBL] [Abstract][Full Text] [Related]
18. Childhood CIDP: Study of 31 patients and comparison between slow and rapid-onset groups.
Cabasson S; Tardieu M; Meunier A; Rouanet-Larriviere MF; Boulay C; Pedespan JM
Brain Dev; 2015 Nov; 37(10):943-51. PubMed ID: 25921353
[TBL] [Abstract][Full Text] [Related]
19. [Indication of autologous stem cell transplantation in chronic inflammatory demyelinating polyneuropathy: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Puyade M; Labeyrie C; Badoglio M; Cintas P; Guenounou S; Lansiaux P; Marjanovic Z; Nicolas G; Pomies A; Terriou L; Torregrosa Diaz JM; Baron C; Castilla Llorente C; Yakoub-Agha I; Farge D
Bull Cancer; 2020 Jan; 107(1S):S104-S113. PubMed ID: 31818426
[TBL] [Abstract][Full Text] [Related]
20. Randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial): a pilot, multicentre study.
RMC Trial Group
Lancet Neurol; 2009 Feb; 8(2):158-64. PubMed ID: 19136303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
